Welcome the Future of Biopharmaceutics

Explore strategies, regulatory validation, and solutions through case studies in small-molecule human Physiologically Based Pharmacokinetic modeling (PBPK).

What you’ll learn

• How PBPK modeling and simulation save time and money while improving internal decision-making processes.
• Case studies illustrating the increased adoption of Model Informed Drug Development (MIDD) and Model Informed Formulation Development (MIFD), using the Simcyp Simulator PBPK platform.
• Biosimulation’s growing acceptance in regulatory decision making.